PAVmed Inc.
Company Information
Industry
Surgical & Medical Instruments & Apparatus
SIC Code
3841
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
360 MADISON AVENUE, NEW YORK, NY, 10017
Mailing Address
360 MADISON AVENUE, NEW YORK, NY, 10017
Phone
(212) 949-4319
Fiscal Year End
1231
EIN
471214177
Financial Overview
FY2025
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 3 Initial insider ownership report | April 6, 2026 | View on SEC |
| 4 Insider stock transaction report | April 3, 2026 | View on SEC |
| 4 Insider stock transaction report | April 3, 2026 | View on SEC |
| 4 Insider stock transaction report | April 3, 2026 | View on SEC |
| 4 Insider stock transaction report | April 3, 2026 | View on SEC |
| 4 Insider stock transaction report | April 3, 2026 | View on SEC |
| 4 Insider stock transaction report | April 3, 2026 | View on SEC |
| SCHEDULE 13G Passive beneficial ownership (>5%) | April 3, 2026 | View on SEC |
| 4 Insider stock transaction report | April 3, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | April 3, 2026 | View on SEC |
Annual Reports
10-K
March 27, 2026
- Significant revenue growth from $0.7 million to $2.8 million year-over-year
- Majority ownership of Lucid Diagnostics, a high-potential medical tech subsidiary
Material Events
8-K
Other
January 23, 2026
High Impact
- PAVmed Inc. has successfully regained full compliance with Nasdaq's listing requirements.
- This resolution removes the risk of delisting, protecting shareholder value and maintaining stock accessibility.
8-K
Financial Distress
December 30, 2025
High Impact
- PAVmed Inc. announced a 1-for-30 reverse stock split.
- The company is also significantly reducing its total authorized shares from 250 million to 25 million.
8-K
Strategy Change
December 5, 2025
High Impact
- PAVmed stockholders approved a reverse stock split and a significant reduction in the total number of authorized shares.
- The board of directors now has the power to implement a reverse stock split with a ratio between 1-for-10 and 1-for-30.
Related Companies
Companies in the same industry (SIC: 3841)
Neuronetics, Inc.
STIM
Surgical & Medical Instruments & Apparatus
NEUROONE MEDICAL TECHNOLOGIES Corp
NMTC
Surgical & Medical Instruments & Apparatus
Cytosorbents Corp
CTSO
Surgical & Medical Instruments & Apparatus
Sight Sciences, Inc.
SGHT
Surgical & Medical Instruments & Apparatus
Penumbra Inc
PEN
Surgical & Medical Instruments & Apparatus
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.